Not applicableUnknownNCT04711954What this trial is testingHIV/COV in Ukraine-NLWho this might be right forHivCovid19 Erasmus Medical Center 1,100
Testing effectiveness (Phase 2)Study completedNCT00000766What this trial is testingCMV Retinitis Retreatment TrialWho this might be right forCytomegalovirus RetinitisHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableStudy completedNCT04373551What this trial is testingWeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP)Who this might be right forHIV-infection/AIDS University of Alabama at Birmingham 67
Early research (Phase 1)Study completedNCT00001041What this trial is testingActive Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)Who this might be right forHIV InfectionsPregnancy National Institute of Allergy and Infectious Diseases (NIAID) 24
Large-scale testing (Phase 3)Study completedNCT00002122What this trial is testingStudy of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected PatientsWho this might be right forMycosesMycobacterium Avium-Intracellulare InfectionHIV Infections Pfizer 720
Large-scale testing (Phase 3)Study completedNCT01608802What this trial is testingOutcomes for Antiretroviral Therapy Patients Receiving Palliative CareWho this might be right forHIV King's College London 240
Not applicableStudy completedNCT00429845What this trial is testingEffect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized TrialWho this might be right forHIV Infections Hospital de Clinicas de Porto Alegre 80
Large-scale testing (Phase 3)Study completedNCT00143702What this trial is testingD4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)Who this might be right forAcidosis, Lactic University of British Columbia 80
Post-approval studies (Phase 4)UnknownNCT03017872What this trial is testingDolutegravir and Darunavir Evaluation in Adults Failing TherapyWho this might be right forHIV Infections Kirby Institute 831
Large-scale testing (Phase 3)Active Not RecruitingNCT04176172What this trial is testingOptimizing Tobacco Use Treatment for PLWHAWho this might be right forHIV/AIDSNicotine Dependence Abramson Cancer Center at Penn Medicine 340
Not applicableLooking for participantsNCT06860945What this trial is testingDevelopment of a Predictive Model for Sexually Transmitted Infections in Individuals Using Pre-Exposure Prophylaxis for HIV in SpainWho this might be right forSexually Transmitted Infections (STIs)HIVPrEP Hospital Universitario de Valme 9,000
Early research (Phase 1)Study completedNCT00001445What this trial is testingPhase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 InfectionWho this might be right forHIV Infection National Cancer Institute (NCI) 32
Early research (Phase 1)Study completedNCT01336829What this trial is testingTMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.Who this might be right forHepatitis CHIV Tibotec Pharmaceuticals, Ireland 33
Early research (Phase 1)Study completedNCT00117429What this trial is testingStudy of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)Who this might be right forHIV Infections Marcus Altfeld, M.D., Ph.D. 20
Early research (Phase 1)Study completedNCT00001053What this trial is testingA Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative SubjectsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableStudy completedNCT05048472What this trial is testingEast Africa Point of Care Viral Load StudyWho this might be right forHIVViral LoadPoint of Care Monitoring MRC/UVRI and LSHTM Uganda Research Unit 956
Testing effectiveness (Phase 2)WithdrawnNCT02462772What this trial is testingSafety and Acceptability of Cabotegravir in HIV Uninfected Women in KwaZulu-Natal, South AfricaWho this might be right forHuman Immunodeficiency Virus Centre for the AIDS Programme of Research in South Africa
Testing effectiveness (Phase 2)Study completedNCT00000851What this trial is testingComparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected ChildrenWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 198
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07675629What this trial is testingEvaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected AdultsWho this might be right forHIV Prevention Worcester HIV Vaccine 126
Early research (Phase 1)Study completedNCT00000887What this trial is testingEvaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their InfantsWho this might be right forHIV InfectionsPregnancy National Institute of Allergy and Infectious Diseases (NIAID) 24